Omnicell is advancing its autonomous pharmacy vision and expanding SaaS offerings, but tariffs and fierce competition could ...
CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate ...
OMCL's autonomous pharmacy strategy, SaaS growth and global expansion boost shares. Can rising costs and tariffs slow the ...
CurifyLabs, a health technology company transforming how personalized medicines are made, today announced the closing of a $14 million Series A funding round. The round was co-led by Sandwater and ...
Judy Faulkner keeps Epic Best in KLAS by focusing on consistency, AI integration, and expanding payer and research platforms.
Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make custom medicine doses.
For an investor who has journeyed through Indian stock markets over the past few years, navigating the Indian healthcare sector in 2026 can feel like walking into a labyrinth. You have watched the ...
Businesses that possess sticky consumer relationships, structural demand insensitivity to economic recessions and excellent ...
The state Medical Board accused a doctor and pharmacist of improperly manufacturing weight loss drugs out of a Sorrento Valley pain clinic.
By ignoring the status quo, Kris Fishman spotted a bottleneck insiders missed—and turned it into a national advantage for one ...
Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital's purchase of Asembia may ...
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results